AU7981791A - Orally administrable gallium compositions and methods of treatment therewith - Google Patents
Orally administrable gallium compositions and methods of treatment therewithInfo
- Publication number
- AU7981791A AU7981791A AU79817/91A AU7981791A AU7981791A AU 7981791 A AU7981791 A AU 7981791A AU 79817/91 A AU79817/91 A AU 79817/91A AU 7981791 A AU7981791 A AU 7981791A AU 7981791 A AU7981791 A AU 7981791A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- orally administrable
- treatment therewith
- gallium compositions
- gallium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52856390A | 1990-05-24 | 1990-05-24 | |
| US528563 | 1990-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7981791A true AU7981791A (en) | 1991-12-10 |
Family
ID=24106201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU79817/91A Abandoned AU7981791A (en) | 1990-05-24 | 1991-05-22 | Orally administrable gallium compositions and methods of treatment therewith |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7981791A (en) |
| WO (1) | WO1991017751A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6004951A (en) * | 1989-11-22 | 1999-12-21 | Bernstein; Lawrence Richard | Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual |
| EP0612246B1 (en) * | 1991-11-12 | 2000-08-30 | BERNSTEIN, Lawrence Richard Dr. | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| US5298525A (en) * | 1992-11-23 | 1994-03-29 | University Technologies International, Inc. | Diabetes prevention and treatment |
| US5747482A (en) * | 1996-07-30 | 1998-05-05 | Bernstein; Lawrence R. | Methods and compositions to inhibit keratinocyte proliferation |
| EP1706148A2 (en) * | 2004-01-14 | 2006-10-04 | Gilead Sciences, Inc. | Lipid-based dispersions useful for drug delivery |
| US20070098815A1 (en) | 2005-10-27 | 2007-05-03 | Bernstein Lawrence R | Orally Administrable Gallium Compositions and Methods of Use |
| EA200801261A1 (en) | 2005-11-04 | 2008-08-29 | Джента Инкорпорейтед | PHARMACEUTICAL COMPOSITIONS BASED ON GALLIUM AND METHODS |
| EP2099464B1 (en) | 2006-11-09 | 2016-05-25 | BERNSTEIN, Lawrence Richard | Local administration of gallium compositions to treat pain |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4591506A (en) * | 1976-10-14 | 1986-05-27 | Bonadio George A H | Oral ingestion of indium |
| US4448763A (en) * | 1980-11-10 | 1984-05-15 | The University Of Kentucky Research Foundation | Alteration of gallium biodistribution using indium complexes for enhanced early imaging |
| FR2500303A1 (en) * | 1981-02-20 | 1982-08-27 | Meram Lab | GALLIUM CHLORIDE, A NEW ANTI-CANCER DRUG |
| EP0109564B1 (en) * | 1982-10-22 | 1988-04-27 | Sloan-Kettering Institute For Cancer Research | The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis |
| EP0107458B1 (en) * | 1982-10-22 | 1987-07-29 | National Research Development Corporation | Pharmaceutical compositions |
| US4704277A (en) * | 1985-04-30 | 1987-11-03 | Sloan-Kettering Institute For Cancer Research | Methods of treating bone disorders |
-
1991
- 1991-05-22 WO PCT/US1991/003599 patent/WO1991017751A1/en not_active Ceased
- 1991-05-22 AU AU79817/91A patent/AU7981791A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991017751A1 (en) | 1991-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4032989A (en) | Method and compositions for the treatment and prevention of septic shock | |
| AU7211787A (en) | Intraocular dosage compositions and method of use | |
| AU573133B2 (en) | Synergistic biocide of 5-chloro-2methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one | |
| AU8117591A (en) | Treatment of water | |
| AU7445594A (en) | Orally administrable opiod formulations having extended duration of effect | |
| EP0581581A3 (en) | Bioadhesive treatment compositions and methods of use | |
| AU4205789A (en) | Method and composition for the treatment and prevention of viral infections | |
| AU3691793A (en) | Gas well treatment compositions and methods | |
| ZA941860B (en) | Halogen compositions for water treatment and method of preparation thereof | |
| AU5590596A (en) | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration | |
| AU3519893A (en) | Antitumor compositions and methods of treatment | |
| AU2260088A (en) | Methods and compositions for the treatment of lung conditions | |
| AU8154294A (en) | Methods of inhibiting atrophy of the skin and vagina | |
| AU8044491A (en) | Antitumor compositions and methods of treatment | |
| SG44524A1 (en) | Methods and compositions of treating malaria and other diseases | |
| AU2114792A (en) | Win 49596-finasteride method of use and compositions | |
| AU8192691A (en) | Method of treatment and compositions therefore | |
| AU7997491A (en) | Extended-release plaque preventing and dissolving compositions and their method of use | |
| AU7981791A (en) | Orally administrable gallium compositions and methods of treatment therewith | |
| AU8427091A (en) | Gamma-carboxylase and methods of use | |
| AU3074592A (en) | Compositions for delayed treatment of ischemia-related neuronal damage | |
| AU7770991A (en) | Method and composition for the treatment of cancer | |
| AU7155491A (en) | Compositions and methods for preventing and treating rotaviral infections | |
| AU5293293A (en) | Methods and compositions for treatment of allergic disease | |
| AU4104093A (en) | Method and compositions for treatment of pyonecrotic processes |